Inflammatory myopathy Biomarker Abnormal movement Anti-interleukin-6 Acid-alpha-glucosidase Anti-drug antibodies Data integration Cytokines Lysosomal storage diseases Biomarqueurs Immunotherapy Antisynthetase syndrome Antiphospholipid syndrome Antisynthétase Assisted communication devices Arthritis AAV vectors Machine learning Sphingosine-1-phosphate Myositis Adeno-associated virus vector Humans IBM Auto-antibodies Anti-MDA5 autoantibodies Adeno-associated virus Inclusion body myositis Skeletal muscle Polymyositis Anti-Mi2 Dermatomyositis Prognosis Outcome measures CD8+ T-bet+ cells Agalsidase AAV humoral immunity Autoantibody Autoimmunity Male Anti-IgE IgG Dependovirus/genetics/immunology IMNM Systems biology Adult DM CD8+T cells Middle Aged Biomarkers Auto‐antibodies Bioelectrical impedance analysis Anti-synthetase syndrome Anticorps anti-agalsidase Cancer Idiopathic inflammatory myopathies COVID-19 B cell homeostasis Active Adjudication Interstitial lung disease Adeno-associated vector Anémie hémolytique Inborn errors of metabolism Anti‐mitochondrial antibodies AAV antibody Analyses multidimensionnelles Aldosterone Adolescence B-lymphocyte Aldostérone Gene therapy Female Antibody responses Amyotrophy Biopsy Mass cytometry Animals Adverse drug reactions Acute Kidney Injury/epidemiology/etiology Antibodies Aged Interferon Amyotrophic lateral sclerosis Muscle Auto-immunité Fabry disease Immune checkpoint inhibitors AAV vector Multidisciplinarity Anti-agalsidase antibodies Inflammation Anticorps spécifique des myosites Myocarditis AAV Deep immune profiling Case reports Autoantibodies Autoimmune diseases Myositis and muscle disease Antisynthetase Myopathy